Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Locally Advanced Rectal Cancer Response to NCT and NCRT With MRI, and Comparison of MR Imaging Evaluation Between NCT and NCRT

NCT04392609 is registered in ClinicalTrials.gov with Ziqiang Wang,MD as lead sponsor.

NCT NCT04392609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04392609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Locally Advanced Rectal Cancer Response to NCT and NCRT With MRI, and Comparison of MR Imaging Evaluation Between NCT and NCRT
Lead sponsor
Ziqiang Wang,MD
Phase
Observational
Overall status
Unknown status
Start date
January 15, 2020
Completion date
July 15, 2020
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mri, rectal cancer